Healthcare Triangle is trading 5.6% up now at $0.75 after announcing on September 17, 2026, that it joined the Kanzun-ARCB Growth Fund as the U.S. technology and capital-markets partner.

  • The initiative is intended to help Malaysian healthcare companies access Middle Eastern capital and prepare for U.S. markets.
  • It supports healthcare technology and AI opportunities and is the clearest company-specific catalyst for the early-session advance.